{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:17:18Z","timestamp":1790921838185,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,21]]},"DOI":"10.7759\/cureus.52675","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T20:27:05Z","timestamp":1705868825000},"source":"Crossref","is-referenced-by-count":6,"title":["Thrombolysis vs Anticoagulation: Unveiling the Trade-Offs in Massive Pulmonary Embolism"],"prefix":"10.7759","author":[{"given":"Tamam","family":"Mohamad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyas","family":"Kanaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikponmwosa  J","family":"Ogieuhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitte Shah","family":"Mannaparambil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubela","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laith Wail Majed","family":"Al-Nazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajra Munir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffer","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendar","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanvi","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/0885066610392658","article-title":"Diagnosis and management of life-threatening pulmonary embolism","volume":"26","author":"Marshall PS","year":"2011","unstructured":"Marshall PS, Mathews KS, Siegel MD. Diagnosis and management of life-threatening pulmonary embolism. J Intensive Care Med. 2011, 26:275-94. 10.1177\/0885066610392658","journal-title":"J Intensive Care Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X10380304","article-title":"Fibrinolysis for acute pulmonary embolism","volume":"15","author":"Piazza G","year":"2010","unstructured":"Piazza G, Goldhaber SZ. Fibrinolysis for acute pulmonary embolism. Vasc Med. 2010, 15:419-28. 10.1177\/1358863X10380304","journal-title":"Vasc Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3400\/avd.oa.22-00111","article-title":"Prognostication of patients with pulmonary thromboembolism with and without residual deep vein thrombosis: a subanalysis of the J'xactly study","volume":"16","author":"Yamada N","year":"2023","unstructured":"Yamada N, Fukuda I, Nakamura M, et al.. Prognostication of patients with pulmonary thromboembolism with and without residual deep vein thrombosis: a subanalysis of the J'xactly study. Ann Vasc Dis. 2023, 16:181-8. 10.3400\/avd.oa.22-00111","journal-title":"Ann Vasc Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2014.05.006","article-title":"Effective diagnosis and treatment of pulmonary embolism: improving patient outcomes","volume":"107","author":"Meyer G","year":"2014","unstructured":"Meyer G. Effective diagnosis and treatment of pulmonary embolism: improving patient outcomes. Arch Cardiovasc Dis. 2014, 107:406-14. 10.1016\/j.acvd.2014.05.006","journal-title":"Arch Cardiovasc Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/hq0701.093686","article-title":"Mechanism of action and pharmacology of unfractionated heparin","volume":"21","author":"Hirsh J","year":"2001","unstructured":"Hirsh J, Anand SS, Halperin JL, Fuster V. Mechanism of action and pharmacology of unfractionated heparin. Arterioscler Thromb Vasc Biol. 2001, 21:1094-6. 10.1161\/hq0701.093686","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013083.pub2","article-title":"Catheter-directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism","volume":"8","author":"Harvey JJ","year":"2022","unstructured":"Harvey JJ, Huang S, Uberoi R. Catheter-directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism. Cochrane Database Syst Rev. 2022, 8:10.1002\/14651858.CD013083.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-023-03528-w","article-title":"Systemic thrombolysis with newer thrombolytics vs anticoagulation in acute intermediate risk pulmonary embolism: a systematic review and meta-analysis","volume":"23","author":"Mathew D","year":"2023","unstructured":"Mathew D, Seelam S, Bumrah K, Sherif A, Shrestha U. Systemic thrombolysis with newer thrombolytics vs anticoagulation in acute intermediate risk pulmonary embolism: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2023, 23:482. 10.1186\/s12872-023-03528-w","journal-title":"BMC Cardiovasc Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2023.100670","article-title":"Effect of pharmacomechanical catheter-directed thrombolysis on segmental artery occlusions: insights from the RESCUE trial","volume":"2","author":"Bashir R","year":"2023","unstructured":"Bashir R, Piazza G, Firth B, et al.. Effect of pharmacomechanical catheter-directed thrombolysis on segmental artery occlusions: insights from the RESCUE trial. JACC Adv. 2023, 2:10.1016\/j.jacadv.2023.100670","journal-title":"JACC Adv"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.039","article-title":"Impact of thrombolytic therapy on\u00a0the\u00a0long-term outcome of intermediate-risk pulmonary\u00a0embolism","volume":"69","author":"Konstantinides SV","year":"2017","unstructured":"Konstantinides SV, Vicaut E, Danays T, et al.. Impact of thrombolytic therapy on\u00a0the\u00a0long-term outcome of intermediate-risk pulmonary\u00a0embolism. J Am Coll Cardiol. 2017, 69:1536-44. 10.1016\/j.jacc.2016.12.039","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12521","article-title":"Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial","volume":"12","author":"Kline JA","year":"2014","unstructured":"Kline JA, Nordenholz KE, Courtney DM, et al.. Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial. J Thromb Haemost. 2014, 12:459-68. 10.1111\/jth.12521","journal-title":"J Thromb Haemost"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr2829w","article-title":"Efficacy and safety of thrombolytic therapy in acute submassive pulmonary embolism: follow-up study","volume":"9","author":"Sinha SK","year":"2017","unstructured":"Sinha SK, Sachan M, Goel A, et al.. Efficacy and safety of thrombolytic therapy in acute submassive pulmonary embolism: follow-up study. J Clin Med Res. 2017, 9:163-9. 10.14740\/jocmr2829w","journal-title":"J Clin Med Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(60)92299-6","article-title":"Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial","volume":"1","author":"Barritt DW","year":"1960","unstructured":"Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet. 1960, 1:1309-12. 10.1016\/s0140-6736(60)92299-6","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.15420\/usc.2016.10.1.30","article-title":"Advanced management options for massive and submassive pulmonary embolism","volume":"10","author":"Malik S","year":"2016","unstructured":"Malik S, Bhardwaj A, Eisen M, Gandhi S. Advanced management options for massive and submassive pulmonary embolism. US Cardiol Rev. 2016, 10:30-5. 10.15420\/usc.2016.10.1.30","journal-title":"US Cardiol Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer G","year":"2014","unstructured":"Meyer G, Vicaut E, Danays T, et al.. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014, 370:1402-11. 10.1056\/NEJMoa1302097","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1378\/chest.15-0119","article-title":"Pulmonary embolism response to fragmentation, embolectomy, and catheter thrombolysis (PERFECT): initial results from a prospective multicenter registry","volume":"148","author":"Kuo WT","year":"2015","unstructured":"Kuo WT, Banerjee A, Kim PS, et al.. Pulmonary embolism response to fragmentation, embolectomy, and catheter thrombolysis (PERFECT): initial results from a prospective multicenter registry. Chest. 2015, 148:667-73. 10.1378\/chest.15-0119","journal-title":"Chest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005544","article-title":"Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism","volume":"129","author":"Kucher N","year":"2014","unstructured":"Kucher N, Boekstegers P, M\u00fcller OJ, et al.. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation. 2014, 129:479-86. 10.1161\/CIRCULATIONAHA.113.005544","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.27193","article-title":"Thrombolysis for pulmonary embolism using the superficial veins of the upper extremity","volume":"90","author":"Kusick J","year":"2017","unstructured":"Kusick J, Salamat J, Sanghvi K. Thrombolysis for pulmonary embolism using the superficial veins of the upper extremity. Catheter Cardiovasc Interv. 2017, 90:996-9. 10.1002\/ccd.27193","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu283","article-title":"2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"Konstantinides SV","year":"2014","unstructured":"Konstantinides SV, Torbicki A, Agnelli G, et al.. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014, 35:3033-69, 3069a-k. 10.1093\/eurheartj\/ehu283","journal-title":"Eur Heart J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021274","article-title":"Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism","volume":"347","author":"Konstantinides S","year":"2002","unstructured":"Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002, 347:1143-50. 10.1056\/NEJMoa021274","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.09.027","article-title":"Moderate pulmonary embolism treated with thrombolysis (from the \"MOPETT\" Trial)","volume":"111","author":"Sharifi M","year":"2013","unstructured":"Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M. Moderate pulmonary embolism treated with thrombolysis (from the \"MOPETT\" Trial). Am J Cardiol. 2013, 111:273-7. 10.1016\/j.amjcard.2012.09.027","journal-title":"Am J Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2011.05.014","article-title":"Catheter-directed ultrasound-accelerated thrombolysis for the treatment of acute pulmonary embolism","volume":"128","author":"Engelhardt TC","year":"2011","unstructured":"Engelhardt TC, Taylor AJ, Simprini LA, Kucher N. Catheter-directed ultrasound-accelerated thrombolysis for the treatment of acute pulmonary embolism. Thromb Res. 2011, 128:149-54. 10.1016\/j.thromres.2011.05.014","journal-title":"Thromb Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e318214914f","article-title":"Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association","volume":"123","author":"Jaff MR","year":"2011","unstructured":"Jaff MR, McMurtry MS, Archer SL, et al.. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011, 123:1788-830. 10.1161\/CIR.0b013e318214914f","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon C","year":"2016","unstructured":"Kearon C, Akl EA, Ornelas J, et al.. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016, 149:315-52. 10.1016\/j.chest.2015.11.026","journal-title":"Chest"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.04.020","article-title":"A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study","volume":"8","author":"Piazza G","year":"2015","unstructured":"Piazza G, Hohlfelder B, Jaff MR, et al.. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study. JACC Cardiovasc Interv. 2015, 8:1382-92. 10.1016\/j.jcin.2015.04.020","journal-title":"JACC Cardiovasc Interv"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman S","year":"2005","unstructured":"Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005, 3:692-4. 10.1111\/j.1538-7836.2005.01204.x","journal-title":"J Thromb Haemost"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a015410","article-title":"Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction","volume":"18","author":"Meneveau N","year":"1997","unstructured":"Meneveau N, Schiele F, Vuillemenot A, Valette B, Grollier G, Bernard Y, Bassand JP. Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction. Eur Heart J. 1997, 18:1141-8. 10.1093\/oxfordjournals.eurheartj.a015410","journal-title":"Eur Heart J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-8703(99)70243-7","article-title":"Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism","volume":"138","author":"Tebbe U","year":"1999","unstructured":"Tebbe U, Graf A, Kamke W, Zahn R, Forycki F, Kratzsch G, Berg G. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism. Am Heart J. 1999, 138:39-44. 10.1016\/s0002-8703(99)70243-7","journal-title":"Am Heart J"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1671-5411.2013.04.005","article-title":"Recombinant tissue plasminogen activator plus heparin compared with heparin alone for patients with acute submassive pulmonary embolism: one-year outcome","volume":"10","author":"Mi YH","year":"2013","unstructured":"Mi YH, Liang Y, Lu YH, Li YM, Liu WX, Qian W. Recombinant tissue plasminogen activator plus heparin compared with heparin alone for patients with acute submassive pulmonary embolism: one-year outcome. J Geriatr Cardiol. 2013, 10:323-9. 10.3969\/j.issn.1671-5411.2013.04.005","journal-title":"J Geriatr Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12393","article-title":"Computed tomography-assessed right ventricular dysfunction and risk stratification of patients with acute non-massive pulmonary embolism: systematic review and meta-analysis","volume":"11","author":"Trujillo-Santos J","year":"2013","unstructured":"Trujillo-Santos J, den Exter PL, G\u00f3mez V, et al.. Computed tomography-assessed right ventricular dysfunction and risk stratification of patients with acute non-massive pulmonary embolism: systematic review and meta-analysis. J Thromb Haemost. 2013, 11:1823-32. 10.1111\/jth.12393","journal-title":"J Thromb Haemost"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.15.1685","article-title":"Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism","volume":"164","author":"ten Wolde M","year":"2004","unstructured":"ten Wolde M, S\u00f6hne M, Quak E, Mac Gillavry MR, B\u00fcller HR. Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. Arch Intern Med. 2004, 164:1685-9. 10.1001\/archinte.164.15.1685","journal-title":"Arch Intern Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(97)00319-7","article-title":"Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry","volume":"30","author":"Kasper W","year":"1997","unstructured":"Kasper W, Konstantinides S, Geibel A, et al.. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol. 1997, 30:1165-71. 10.1016\/s0735-1097(97)00319-7","journal-title":"J Am Coll Cardiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.413","article-title":"The post-thrombotic syndrome","volume":"2016","author":"Kahn SR","year":"2016","unstructured":"Kahn SR. The post-thrombotic syndrome. Hematology Am Soc Hematol Educ Program. 2016, 2016:413-8. 10.1182\/asheducation-2016.1.413","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-015-1312-5","article-title":"Guidance for the prevention and treatment of the post-thrombotic syndrome","volume":"41","author":"Kahn SR","year":"2016","unstructured":"Kahn SR, Galanaud JP, Vedantham S, Ginsberg JS. Guidance for the prevention and treatment of the post-thrombotic syndrome. J Thromb Thrombolysis. 2016, 41:144-53. 10.1007\/s11239-015-1312-5","journal-title":"J Thromb Thrombolysis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.925651","article-title":"Postthrombotic syndrome. Cardiology patient page","volume":"121","author":"Vazquez SR","year":"2010","unstructured":"Vazquez SR, Kahn SR. Postthrombotic syndrome. Cardiology patient page. Circulation. 2010, 121:217-9. 10.1161\/CIRCULATIONAHA.109.925651","journal-title":"Circulation"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60962-2","article-title":"Risk assessment for recurrent venous thrombosis","volume":"376","author":"Kyrle PA","year":"2010","unstructured":"Kyrle PA, Rosendaal FR, Eichinger S. Risk assessment for recurrent venous thrombosis. Lancet. 2010, 376:2032-9. 10.1016\/S0140-6736(10)60962-2","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/224022-thrombolysis-vs-anticoagulation-unveiling-the-trade-offs-in-massive-pulmonary-embolism","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:12Z","timestamp":1707509532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/224022-thrombolysis-vs-anticoagulation-unveiling-the-trade-offs-in-massive-pulmonary-embolism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,21]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.52675","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,21]]}}}